Abstract:<p>Nucleic acid detection is a necessary part of medical treatment and field work. However, the current detection technologies are far from ideal. A lack of timely and accessible testing for identifying cases and close contacts has allowed SARS‐CoV‐2, the causative virus of the ongoing COVID‐19 pandemic, to spread uncontrollably. The slow and expensive detection of mutations – predictors for chronic diseases such as cancer – form a barrier to personalized treatment. A recently developed diagnostic assay is ideal and field‐ready – it relies on CRISPR‐Cas13. CRISPR‐Cas13 works similarly to other CRISPR systems: Cas13 is guided by a crRNA to cleave next to a specific RNA target sequence. Additionally, Cas13 boasts a unique collateral cleavage activity; collateral cleavage of a fluorescent reporter detects the presence of the target sequence in sample RNA. This system forms the basis of CRISPR‐Cas13 diagnostic assays. CRISPR‐Cas13 assays have >95% sensitivity and >99% specificity. Detection is rapid (2 hours), inexpensive ($0.05), and portable – a test using a lateral flow strips is akin to a pregnancy test. The recent adaptation of micro‐well chips facilitates high‐level multiplexing and is high‐throughput. In this review, we cover the development of CRISPR‐Cas13 assays for medical diagnosis, discuss the advantages of CRISPR‐Cas13‐based diagnosis over traditional RT‐PCR, and present examples of detection from real patient samples.</p><p>This article is protected by copyright. All rights reserved.</p>

Improved Strategies for CRISPR-Cas12-based Nucleic Acids Detection

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Powerful CRISPR-Based Biosensing Techniques and Their Integration With Microfluidic Platforms

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

CRISPR-Cas based virus detection: Recent advances and perspectives

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Amplification-free CRISPR/Cas detection technology: challenges, strategies, and perspectives.

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives

Development and application of sensitive, specific, and rapid CRISPR‐Cas13‐based diagnosis

Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19

Recent Improvements in CRISPR-Based Amplification-Free Pathogen Detection

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Novel nucleic acid detection strategies based on CRISPR‐Cas systems: From construction to application

CRISPR Cas system: A strategic approach in detection of nucleic acids

Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

CRISPR/Cas-Powered Amplification-Free Detection of Nucleic Acids: Current State of the Art, Challenges, and Futuristic Perspectives